JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
There are no items in your shopping cart
Featured Products
Axon 3952
CAS [1363154-45-3]
MF C19H22N4O4SMW 402.47
GNI-50 is an orally active NAMPT inhibitor which exhibited excellent biochemical and cellular (A2780) potency with IC50 values of 0.007 μM and 0.032 μM, respectively. GNI-50 also showed excellent in vivo antitumor efficacy when dosed orally in an A2780 ovarian tumor xenograft model.
KEYWORDS: GNI-50 | Supplier | NAMPT inhibitor | SBI796768 | GNI50 | GNI 50 | SBI 796768 | SBI796768 | CAS [1363154-45-3] | Nicotinamide D-ribonucleotide | NAMPT | Inhibitor | Enzymes | Nicotinamide phosphoribosyltransferase | Ovarian tumor
1-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-ylsulfonyl)phenyl)-3-(pyridin-3-ylmethyl)urea
[1363154-45-3]
The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.
Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!
* Required Fields